By Vivek Kumar M and Bharath Rajeswaran (Reuters) -Indian equity benchmarks posted a second straight weekly loss, weighed ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

The Sensex and the Nifty 50 declined by almost a per cent each on Friday, July 11. The Sensex closed 690 points, or 0.83 per ...

India's benchmark shares were muted on Tuesday after U.S. President Donald Trump delayed implementation of tariffs to August ...

Indian equity benchmarks ended little changed on Monday as gains in consumer stocks, led by Godrej Consumer, helped offset ...

Several companies, including Tata Consultancy Services and Bharti Airtel, will trade ex-dividend from July 14 to 18, ...

Japan's Omron is planning to boost its presence in the Indian market, its CEO said on Thursday, as a surge in hypertension ...

India’s derivatives boom is a remarkable story of financial inclusion and technological scale. But scale alone isn’t a ...

The B2B education platform views its listing on Indian bourses as a major step towards enhancing its global expansion.

A temporary trading ban imposed by India’s securities regulator on Jane Street Group LLC is fueling concerns that volumes in ...

Tesla Inc. will open its first showroom in India on Tuesday and begin deliveries as early as next month, according to people familiar with the matter, as the Elon Musk-led electric vehicle maker looks ...